Korro Bio

Provider of RNA editing technologies to develop genetic medicines for rare and prevalent diseases

placeCambridge, Massachusetts, United States calendar_todayFounded 2018 groups77 employees language korrobio.com

Registered entities

Social engagement

Social engagement: 13.3K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

16 investors on record; 1 has since exited.

Investor typeCountShare
Venture capital744%
Private equity213%
Other / undisclosed744%

Hiring activity

Hires periodically

3 roles tracked across 3 of the last 12 months

10 Jun 2026 · Director, CMC QA · Cambridge

15 Jan 2026 · Senior Manager, Clinical Operations · Cambridge

21 Nov 2025 · Vice President/Senior Vice President, Clinical Development · Cambridge

22 Jun 2025 · Vice President, Quality · Cambridge

Based on job postings tracked across public sources.

Recent activity

15 May 2026
Event
ASGCT2026
28 Jan 2026
Event
Virtual Analyst Day discussion on KRRO-121 for hyperammonemia
26 Jan 2026
Event
Korro Bio's virtual Analyst Day
Coming soon